News | EP Mapping and Imaging Systems | June 12, 2018

Volta Medical Brings Artificial Intelligence to Cardiac Electrophysiology

Smart software AIFib guides cardiologists through atrial fibrillation procedures

Volta Medical Brings Artificial Intelligence to Cardiac Electrophysiology

June 12, 2018 — Volta Medical, out of Marseille, France, has developed the first artificial intelligence (AI) software to guide cardiologists during heart surgeries to treat atrial fibrillation (AF) or any open-heart surgery.

In January 2017, the co-founders published their first article in the Journal of the American College of Cardiology (JACC) that had garnered great interest in the field.

AIFib is an artificial intelligence software developed to guide doctors through the complex medical procedure intended to treat atrial fibrillation — from the detection of electrical foci, which trigger atrial fibrillation, to the surgery itself. AIFib is based on more than 10 years of intense research and development by the co-founders, alongside a team of engineers led by Théophile Mohr Durdez, who developed the software and runs the company.

At the 2018 Heart Rhythm Society (HRS) Conference, May 9-12 in Boston, Jérôme Kalifa, M.D., Ph.D., co-founder of Volta Medical, presented the results of a test performed by 28 expert cardiologists and Volta's software. The test consisted of analyzing intracardiac electrical signals during the surgical ablation of atrial fibrillation, and the performance of the AIFib software surpassed those recorded a few months earlier by a panel of 28 cardiologists. Studies are underway to confirm this promising preliminary data.

To identify electrical foci, the root cause of fibrillation, cardiologists previously had to manipulate probes inside the heart in order to identify the electrical signals and detect them visually. The technique is hard to master, however, and surgeons have to analyze very complex sets of intracardiac electrical signals. Volta Medical had the idea to model and automate this technique as a way to make it accessible to a large number of surgeons.

AF manifests itself by an anarchic, rapid and irregular heart rate. These chaotic heartbeats prevent the heart from properly pumping blood. The root cause is an "electrical storm" in the atria disrupting all synchronized activities to a point that the mechanical contraction of the atria no longer occurs. The heart loses its strength. The ventricle may momentarily compensate for this loss, but in the long run, the exhaustion of its contractile forces can lead to heart failure. Atrial fibrillation can cause a blood clot in the heart, which may migrate into the brain arteries and cause a stroke.

For more information: www.volta-medical.com

References

Seitz J., Bars C., Théodore G., et al. "AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach." Journal of the American College of Cardiology, Jan. 24, 2017. DOI: 10.1016/j.jacc.2016.10.065


Related Content

News | Artificial Intelligence

April 4, 2025 — Viz.ai has been named an Award Winner in the 2025 Edison Awards, for the third year in a row. Viz HCM ...

Home April 07, 2025
Home
News | Artificial Intelligence

March 3, 2025 — Microsoft Corp. has unveiled Microsoft Dragon Copilot, an AI assistant for clinical workflow that brings ...

Home March 03, 2025
Home
News | Artificial Intelligence

Feb. 25, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD) management, recently ...

Home February 26, 2025
Home
News | Artificial Intelligence

Feb. 6, 2025 — Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung ...

Home February 10, 2025
Home
News | Artificial Intelligence

Feb. 4, 2025 — Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 ...

Home February 04, 2025
Home
News | Artificial Intelligence

Jan. 22, 2025 — Public Responsibility in Medicine and Research (PRIM&R) recently called for establishing clear ethical ...

Home January 23, 2025
Home
News | Artificial Intelligence

Jan. 22, 2025 -- HeartFlow, Inc., a provider of non-invasive artificial intelligence (AI) heart care solutions, and ...

Home January 23, 2025
Home
News | Artificial Intelligence

Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 ...

Home December 05, 2024
Home
News | Artificial Intelligence

Oct. 30, 2024 — HeartLung Technologies, a developer of AI tools for early detection of heart disease, lung cancer and ...

Home October 30, 2024
Home
News | Artificial Intelligence

Oct. 27, 2024 — Investigators from Gifu Heart Center and Fukuoka Sanno Hospital recently presented the results of the ...

Home October 29, 2024
Home
Subscribe Now